Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

328 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details
Completed

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

NCT02091141

Conditions
Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +16 more
Locations
  • Western Regional Medical Center at Cancer Treatment Centers of America Goodyear, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Science 37, Inc Culver City, California, United States
View all 60 locations
View Trial Details
Completed

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

NCT04677504

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Duke Cancer Center Durham, North Carolina, United States
  • Sarah Cannon Research Institute / Tennessee Oncology Nashville, Tennessee, United States
View all 49 locations
View Trial Details
Completed

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

NCT05074472

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Cancer Metastatic, +27 more
Locations
  • Mayo Clinic - Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Completed

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

NCT03230318

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Completed

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

NCT03531320

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
Locations
  • China Medical University Hospital Taichung, Taiwan
  • National Cheng-Kung University Hospital Tainan, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • Taipei Veterans General Hospital Taipei, Taiwan
View Trial Details

Related conditions